Meta-Analysis of Prostatic Artery Embolization for Benign Prostatic Hyperplasia

PAE provided improvement in Qmax, PVR, IPSS, and QOL endpoints at 12 months, with a low incidence of serious AEs (0.3%), although minor AEs were common (32.93%). There was no adverse effect on erectile function.